Table 1.

Demographic Characteristics at Enrollment: Total Vaccinated Cohort

Age 3–17 y
Age 6–35 mo
QIV
(N = 932)
TIV-Vic (N = 929)TIV-Yam (N = 932)QIV
(N = 301)
Mean age in years (SD; median; range)8.9 (4.21; 8.0; 3–17)8.9 (4.23; 9.0; 2–17)8.9 (4.17; 9.0; 3–17)1.2 (0.73; 1.0; 0–2)
Mean age in months (SD; median; range)112.4 (51.06; 107.0; 36–215)111.8 (51.10; 108.0; 34–215)111.8 (50.08; 108.5; 36–215)21.0 (8.68; 21.0; 6–35)
Male, n (%)498 (53.4)474 (51.0)468 (50.2)158 (52.5)
Female, n (%)434 (46.6)455 (49.0)464 (49.8)143 (47.5)
Hispanic/Latino ethnicity235 (25.2)235 (25.3)245 (26.3)56 (18.6)
Not Hispanic/Latino ethnicity697 (74.8)694 (74.7)687 (73.7)245 (81.4)
Heritage/race
  European heritage/Caucasian598 (64.2)580 (62.4)575 (61.7)206 (68.4)
  Asian119 (12.8)125 (13.6)125 (13.4)18 (5.9)
  African heritage/African American83 (8.9)85 (9.1)87 (9.3)48 (15.9)
  American Indian/native Alaskan6 (0.6)1 (0.1)1 (0.1)6 (2.0)
  Pacific Islander/native Hawaiian3 (0.3)1 (0.1)4 (0.4)0
  Other123 (13.2)137 (14.7)140 (15.0)23 (7.6)
Age 3–17 y
Age 6–35 mo
QIV
(N = 932)
TIV-Vic (N = 929)TIV-Yam (N = 932)QIV
(N = 301)
Mean age in years (SD; median; range)8.9 (4.21; 8.0; 3–17)8.9 (4.23; 9.0; 2–17)8.9 (4.17; 9.0; 3–17)1.2 (0.73; 1.0; 0–2)
Mean age in months (SD; median; range)112.4 (51.06; 107.0; 36–215)111.8 (51.10; 108.0; 34–215)111.8 (50.08; 108.5; 36–215)21.0 (8.68; 21.0; 6–35)
Male, n (%)498 (53.4)474 (51.0)468 (50.2)158 (52.5)
Female, n (%)434 (46.6)455 (49.0)464 (49.8)143 (47.5)
Hispanic/Latino ethnicity235 (25.2)235 (25.3)245 (26.3)56 (18.6)
Not Hispanic/Latino ethnicity697 (74.8)694 (74.7)687 (73.7)245 (81.4)
Heritage/race
  European heritage/Caucasian598 (64.2)580 (62.4)575 (61.7)206 (68.4)
  Asian119 (12.8)125 (13.6)125 (13.4)18 (5.9)
  African heritage/African American83 (8.9)85 (9.1)87 (9.3)48 (15.9)
  American Indian/native Alaskan6 (0.6)1 (0.1)1 (0.1)6 (2.0)
  Pacific Islander/native Hawaiian3 (0.3)1 (0.1)4 (0.4)0
  Other123 (13.2)137 (14.7)140 (15.0)23 (7.6)

Abbreviations: QIV, quadrivalent influenza vaccine; SD, standard deviation; TIV-Vic, trivalent influenza vaccine Victoria lineage B strain; TIV-Yam, trivalent influenza vaccine Yamagata lineage B strain.

Table 1.

Demographic Characteristics at Enrollment: Total Vaccinated Cohort

Age 3–17 y
Age 6–35 mo
QIV
(N = 932)
TIV-Vic (N = 929)TIV-Yam (N = 932)QIV
(N = 301)
Mean age in years (SD; median; range)8.9 (4.21; 8.0; 3–17)8.9 (4.23; 9.0; 2–17)8.9 (4.17; 9.0; 3–17)1.2 (0.73; 1.0; 0–2)
Mean age in months (SD; median; range)112.4 (51.06; 107.0; 36–215)111.8 (51.10; 108.0; 34–215)111.8 (50.08; 108.5; 36–215)21.0 (8.68; 21.0; 6–35)
Male, n (%)498 (53.4)474 (51.0)468 (50.2)158 (52.5)
Female, n (%)434 (46.6)455 (49.0)464 (49.8)143 (47.5)
Hispanic/Latino ethnicity235 (25.2)235 (25.3)245 (26.3)56 (18.6)
Not Hispanic/Latino ethnicity697 (74.8)694 (74.7)687 (73.7)245 (81.4)
Heritage/race
  European heritage/Caucasian598 (64.2)580 (62.4)575 (61.7)206 (68.4)
  Asian119 (12.8)125 (13.6)125 (13.4)18 (5.9)
  African heritage/African American83 (8.9)85 (9.1)87 (9.3)48 (15.9)
  American Indian/native Alaskan6 (0.6)1 (0.1)1 (0.1)6 (2.0)
  Pacific Islander/native Hawaiian3 (0.3)1 (0.1)4 (0.4)0
  Other123 (13.2)137 (14.7)140 (15.0)23 (7.6)
Age 3–17 y
Age 6–35 mo
QIV
(N = 932)
TIV-Vic (N = 929)TIV-Yam (N = 932)QIV
(N = 301)
Mean age in years (SD; median; range)8.9 (4.21; 8.0; 3–17)8.9 (4.23; 9.0; 2–17)8.9 (4.17; 9.0; 3–17)1.2 (0.73; 1.0; 0–2)
Mean age in months (SD; median; range)112.4 (51.06; 107.0; 36–215)111.8 (51.10; 108.0; 34–215)111.8 (50.08; 108.5; 36–215)21.0 (8.68; 21.0; 6–35)
Male, n (%)498 (53.4)474 (51.0)468 (50.2)158 (52.5)
Female, n (%)434 (46.6)455 (49.0)464 (49.8)143 (47.5)
Hispanic/Latino ethnicity235 (25.2)235 (25.3)245 (26.3)56 (18.6)
Not Hispanic/Latino ethnicity697 (74.8)694 (74.7)687 (73.7)245 (81.4)
Heritage/race
  European heritage/Caucasian598 (64.2)580 (62.4)575 (61.7)206 (68.4)
  Asian119 (12.8)125 (13.6)125 (13.4)18 (5.9)
  African heritage/African American83 (8.9)85 (9.1)87 (9.3)48 (15.9)
  American Indian/native Alaskan6 (0.6)1 (0.1)1 (0.1)6 (2.0)
  Pacific Islander/native Hawaiian3 (0.3)1 (0.1)4 (0.4)0
  Other123 (13.2)137 (14.7)140 (15.0)23 (7.6)

Abbreviations: QIV, quadrivalent influenza vaccine; SD, standard deviation; TIV-Vic, trivalent influenza vaccine Victoria lineage B strain; TIV-Yam, trivalent influenza vaccine Yamagata lineage B strain.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close